| Gestational age | |
| <34 weeks | 3 (0.8) |
| 34–37 weeks | 32 (8.3) |
| ≥37 weeks | 346 (91.1) |
| Unknown | 3 (0.8) |
| EFW (g) (mean±SD) | 3,026.6±373.6 |
| Gestational diabetes | 85 (22.1) |
| Premature rupture of membranes | 72 (18.8) |
| Group B Streptococcus (GBS) positive status | 33 (8.6) |
| Gestational hypertension | 11 (2.9) |
| Intrauterine growth restriction (IUGR) | 9 (2.3) |
| Labor induction | 37 (9.6) |
| Epidural analgesia | 229 (59.6) |
| Oxytocin use in labor | 78 (20.3) |
| Active labor duration (hours) (mean±SD) | 3.3±2.4 |
| Perineal length (cm) (mean±SD) | 4.0±0.7 |
| Fetal heart rate monitoring | |
| Category I | 229 (59.6) |
| Category II | 152 (39.6) |
| Not monitored | 3 (0.8) |
| Total vaginal exams (mean±SD) | 7.2±2.9 |
| Duration of the second stage of labor (minutes) (mean±SD) | 34.5±35.6 |
| Birth attendants | |
| Midwife | 122 (31.8) |
| Attending doctor | 120 (31.3) |
| Private doctor | 115 (29.9) |
| Trainee | 27 (7.0) |